Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. W.H. Wilson Tang provides an overview of novel approaches defining HFpEF and management strategies.

Patients who present with angina or even myocardial infarction may show mild or no coronary artery disease on coronary angiography. This condition, called INOCA or ischemia with no obstructive coronary arteries, is caused by microvascular dysfunction or vasospastic disorders. Dr. Khaled Ziada, a cardiologist at Cleveland Clinic specializes in this disorder and discuss how this condition is diagnosed and currently treated.

Dr. Saliba and Dr. Wazni discuss the challenges of patients who would like to stop anticoagulation after atrial fibrillation ablation. The OPTION study is a research trial looking at the safety and effectiveness of the WATCHMAN device used for left atrial appendage closure vs. oral anticoagulants in patients with non valvular atrial fibrillation.

Dr. Eric Roselli and Dr. Amit Goyal discuss cardio-obstetrics and a team based approach to patient care.

Aorta Center vascular surgeon Dr. Sean Lyden and cardiovascular medicine specialist Dr. Scott Cameron talk about information providers may find helpful, such as screening guidelines; risk factors; unusual findings during a physical exam; when patients should be referred to an aortic specialist; and treatment options from minimally invasive to open approaches

Dr. Eric Roselli discusses thoracic aortic aneurysms, highlighting two case presentations and root replacement operative considerations.

Dr. Steve Nissen, Chief Academic Officer, Cleveland Clinic Miller Family Heart, Vascular & Thoracic Institute talks about three trials presented at the 2020 AHA Scientific Sessions: the STRENGTH trial (omega 3 fatty acid’s impact on cardiovascular events) ; STOP AF trial (medication vs. ablation in treating patients with new onset atrial fibrillation); and the RHAPSODY trial (randomized trial of rilonacept in the treatment of recurrent pericarditis). He also provides his take on the SAMSON trial (symptoms related to statins vs. placebo) and TIPS-3 (an international poly-pill study).

Dr. Eric Roselli and Dr. Amit Goyal discuss cardiac arrest and deep dive on a patient rescue.

Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial, a pivotal Phase 3 trial that evaluated rilonacept, an interleukin 1-α and 1-β inhibitor, compared with placebo among patients with recurrent pericarditis. Study design and findings are provided, as well as implications for future care for patients with pericarditis.

Dr. Eric Roselli and Dr. Amit Goyal discuss 2000 Heart Transplants at the Cleveland Clinic.